In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Replimune Group Inc (NASDAQ: REPL) closed at $4.35 down -4.61% from its previous closing price of $4.56. In other words, the price has decreased by -$4.61 from its previous closing price. On the day, 3.74 million shares were traded. REPL stock price reached its highest trading level at $4.51 during the session, while it also had its lowest trading level at $4.295.
Ratios:
For a deeper understanding of Replimune Group Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.94 and its Current Ratio is at 6.94. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 15 ’25 when Hill Emily Luisa sold 9,154 shares for $5.37 per share. The transaction valued at 49,157 led to the insider holds 134,368 shares of the business.
Astley-Sparke Philip sold 32,279 shares of REPL for $260,169 on May 20 ’25. The Director now owns 1,405,071 shares after completing the transaction at $8.06 per share. On May 20 ’25, another insider, Xynos Konstantinos, who serves as the Chief Medical Officer of the company, sold 7,952 shares for $8.06 each. As a result, the insider received 64,093 and left with 146,933 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 339542944 and an Enterprise Value of 12529930.
Stock Price History:
The Beta on a monthly basis for REPL is 0.69, which has changed by -0.61875546 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $2.68. The 50-Day Moving Average of the stock is -14.66%, while the 200-Day Moving Average is calculated to be -51.33%.
Shares Statistics:
For the past three months, REPL has traded an average of 9.98M shares per day and 2877900 over the past ten days. A total of 77.81M shares are outstanding, with a floating share count of 66.34M. Insiders hold about 15.01% of the company’s shares, while institutions hold 96.85% stake in the company. Shares short for REPL as of 1759190400 were 17884459 with a Short Ratio of 1.79, compared to 1756425600 on 18572217. Therefore, it implies a Short% of Shares Outstanding of 17884459 and a Short% of Float of 43.04.
Earnings Estimates
The stock of Replimune Group Inc (REPL) is currently being evaluated by 7.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.78, with high estimates of -$0.6 and low estimates of -$0.91.
Analysts are recommending an EPS of between -$2.85 and -$3.67 for the fiscal current year, implying an average EPS of -$3.2. EPS for the following year is -$2.01, with 6.0 analysts recommending between -$1.24 and -$2.97.
